- Home
- BGSF vs TVGN Comparison
BGSF vs TVGN Comparison
Compare BGSF & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$5.53
Company Overview
Basic Information| Metric | BGSF | TVGN |
|---|---|---|
| Founded | 2007 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Blank Checks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.0M | 63.9M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | BGSF | TVGN |
|---|---|---|
| Price | $5.53 | $9.92 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.6K | ★ 30.9K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | ★ 36.04% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $93,310,000.00 | N/A |
| Revenue This Year | $4.67 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.26 | $0.14 |
| 52 Week High | $8.20 | $12.03 |
Technical Indicators
Market Signals| Indicator | BGSF | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 60.67 | 52.89 |
| Support Level | $5.49 | $0.39 |
| Resistance Level | $5.79 | $10.08 |
| Average True Range (ATR) | 0.18 | 1.35 |
| MACD | 0.06 | -0.16 |
| Stochastic Oscillator | 90.65 | 49.83 |
Price Performance
Historical Comparison BGSF
TVGN
About BGSF BGSF Inc.
BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. The company operates in one segment of Property Management, which includes centralized support services through executive, marketing, human resources, information technology, accounting, treasury, and billing operations.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.